Clinical outcomes of Preimplantation genetic testing (PGT) application in couples with chromosomal inversion, a study in the Chinese Han population.

BACKGROUND: Chromosomal inversion was considered to have adverse effects on pregnancy outcomes through abnormal gametogenesis. The purpose of this retrospective study was to investigate whether preimplantation genetic testing (PGT) improves pregnancy outcomes for couples with chromosomal inversion. METHODS: A total of 188 cycles from 165 couples with one chromosomal inversion carrier were divided into two groups: PGT (136 cycles, 125 couples) and non-PGT (52 cycles, 50 couples). Biochemical pregnancy, clinical pregnancy, ongoing pregnancy, miscarriage and live birth rates of their first transfer cycles, as well as cumulative live birth rates of each cycle and euploidy rates, were analyzed. RESULTS: There were no statistically significant differences in the pregnancy outcomes between the two groups. The euploidy rate of pericentric inversion carriers was not higher than that of paracentric inversion carriers in PGT group (60.71% vs 50.54%, P = 0.073). Similarly, the euploid rate of male carriers was not higher than that of female carriers (61.2% vs 56.1%, P = 0.256). CONCLUSIONS: Due to limitation of retrospective study and small sample size, our current data showed that PGT cannot provide prominent benefits for inversion carriers in the Chinese Han population. Further prospective randomized controlled trials are needed to evaluate the effects of PGT.

Inv dup del(10p): Prenatal diagnosis and molecular cytogenetic characterization.

OBJECTIVE: We present molecular cytogenetic characterization of prenatally detected inverted duplication and deletion of 10p [inv dup del(10p)]. CASE REPORT: A 39-year-old, primigravid woman underwent amniocentesis at 17 weeks of gestation because of advanced maternal age. Amniocentesis revealed a derivative chromosome 10 with additional material at the end of the short arm of one chromosome 10. Simultaneous array comparative genomic hybridization (aCGH) analysis revealed the result of arr 10p15.3 (136,361-451,013) × 1, 10p15.3p12.1 (536,704-25,396,900) × 3 [GRCh37 (hg19)] with a 0.31-Mb deletion of 10p15.3 encompassing ZMYND11 and DIP2C, and a 24.86-Mb duplication of 10p15.3p12.1. The pregnancy was subsequently terminated, and a female fetus was delivered with facial dysmorphism. Postnatal aCGH analysis showed that the umbilical cord had the same result as that of amniotic fluid, whereas the placenta had only the deletion of 10p15.3. Fluorescence in situ hybridization (FISH) analysis of the cord blood confirmed inverted duplication and deletion of 10p. The cord blood had a karyotype of 46,XX,der(10) del(10) (p15.3)dup(10) (p15.3p12.1)dn. Polymorphic DNA marker analysis confirmed a maternal origin of the chromosome 10 aberration. CONCLUSION: Prenatal diagnosis of inv dup del(10p) with haploinsufficiency of ZMYND11 should include a genetic counseling of mental retardation and chromosome 10p15.3 microdeletion syndrome. aCGH, FISH and polymorphic DNA marker analysis are useful for perinatal investigation of inv dup del(10p).

Retrospective analysis of meiotic segregation pattern and interchromosomal effects in blastocysts from inversion preimplantation genetic testing cycles.

OBJECTIVE: To determine factors affecting unbalanced chromosomal rearrangement originating from parental inversion and interchromosomal effect occurrence in blastocysts from inversion carriers. DESIGN: Retrospective study. SETTING: University-affiliated center. PATIENT(S): Couples with one partner carrying inversion underwent preimplantation genetic testing for chromosomal structural rearrangement cycles. INTERVENTION(S): Not applicable. MAIN OUTCOME MEASURE(S): Unbalanced rearrangement embryo rate, normal embryo rate, interchromosomal effect. RESULT(S): Preimplantation genetic testing was performed for 576 blastocysts from 57 paracentric (PAI) and 94 pericentric (PEI) inversion carriers. The percentage of normal/balanced blastocysts was significantly higher in PAI than PEI carriers (70.4% vs. 57.5%). Logistic regression indicated the inverted segment size ratio was a statistically significant risk factor for abnormality from parental inversion in both PEI and PAI. The optimal cutoff values to predict unbalanced rearrangement risk were 35.7% and 57%. In PAI, rates of abnormality from parental inversion were 0% and 12.1% in the <35.7% and ≥35.7% groups, respectively, with no gender difference. For PEI, the rates of abnormality from parental inversion were 7.9% and 33.1% in the <57% and ≥57% groups, respectively. In the ≥57% group, the rate of unbalanced rearrangement was significantly higher from paternal than maternal inversion (43.3% vs. 23.6%). In inversion carriers, 21,208 chromosomes were examined, and 187 (0.88%) malsegregations were identified from structurally normal chromosomes. In controls, 56,488 chromosomes were assessed, and 497 (0.88%) aneuploidies were identified, indicating no significant difference. CONCLUSION(S): The risk of unbalanced rearrangement is affected by the ratio of inverted segment size in both PAI and PEI carriers and is associated with gender.

Clinical, cytogenetic, and molecular analyses of prenatally diagnosed mosaic tetrasomy for distal chromosome 15q and review of the literature.

OBJECTIVES: To present prenatally detected mosaic tetrasomy for distal chromosome 15q and a review of the literature. CLINICAL SUBJECT AND METHODS: Amniocentesis was performed at 17 weeks' gestation because of advanced maternal age. Cytogenetic analysis revealed mosaicism for an analphoid supernumerary marker chromosome (SMC). The parental karyotypes were normal. Fluorescence in situ hybridization (FISH) and polymorphic DNA marker analysis were applied to study the origin of the SMC. Level II ultrasound revealed gastric dilation. The pregnancy was terminated, and a malformed fetus was delivered with characteristic dysmorphism. Multiple samplings of fetal and extraembryonic tissues were performed to investigate the mosaicism. RESULTS: Initial amniocentesis revealed mos 47,XY,+ mar[20]/46,XY[1], and repeat amniocentesis revealed 47,XY,+ mar[28]/46,XY[8]. FISH and polymorphic DNA marker analysis determined an origin from the distal 15q and an inverted duplication of 15q25.3 --> qter for the SMC. Karyotype of the fetus was designated as 47,XY,+ ace i(15) (qter --> q25.3::q25.3 --> qter)/46,XY de novo. The levels of tetrasomy for distal 15q were 28/40 in cord blood, 13/40 in liver, 14/40 in lungs, 27/40 in skin, 0/40 in placenta, and 40/40 in umbilical cord. The placenta showed an equal biparental inheritance (1:1). The umbilical cord inherited one copy of a paternal allele and three copies of a maternal allele (1:3) at distal 15q. Diallelic patterns with dosage ratios (paternal allele: maternal allele) of 1:2.5 in amniocytes, 1:2.3 in amnion, 1:2.2 in cord blood, 1:2.1 in skin, 1:1.4 in liver, and 1:1.4 in lungs. A maternal origin of the mosaic SMC(15) was determined. CONCLUSIONS: A diagnosis of mosaic analphoid SMCs in amniocytes should alert mosaic mirror-image duplication of euchromatin from some distal chromosomal segment such as distal 15q or distal 13q, and a risk for fetal abnormalities. Fetuses with mosaic tetrasomy for distal 15q may be associated with fetoplacental chromosomal discrepancy. Postnatal samplings of umbilical cord, placenta and amniotic membrane may provide additional clues to the cytogenetic discrepancy between fetal and extraembryonic tissues in prenatally detected mosaic analphoid SMCs.